Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-10-22

Clinical Trial Update: Kaletra-isentress Treatment Evaluation [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating Kaletra (lopinavir/ritonavir) with Isentress (raltegravir) in HIV infection has completed and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Isentress (Raltegravir)
  • Kaletra (lopinavir)

Snippet

Sponsor: Emory University | Conditions: HIV Infections | Phase 4 | Status: COMPLETED | Results posted: 2013-10-22